Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest Drugs in Development and Pipeline Prospector News of FarmaMondo.

    Client Virtual Booth

    FARMAMONDO

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    FarmaMondo
    Switzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Piazza Indipendenza 3b, Chiasso
    Telephone
    Telephone
    +41916976370
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://farmamondo.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/farma-mondo-sa/
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Farma Mondo Group and Helsinn Sign Exclusive Partnership To Commercialize AKYNZEO® In The Baltic Region

    Details:

    Under the terms of the agreement, Farma Mondo will manage the commercialization of AKYNZEO® in Estonia and Latvia. AKYNZEO® hard capsules (combination of netupitant/palonosetron), for the treatment of chemotherapy-induced nausea and vomiting (CINV) in adults.


    Lead Product(s): Netupitant,Palonosetron

    Therapeutic Area: Gastroenterology Product Name: Akynzeo

    Highest Development Status: ApprovedProduct Type: Small molecule

    Partner/Sponsor/Collaborator: Helsinn Group

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Partnership November 28, 2022

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Dompé and The FarmaMondo Group Enter Agreement to Distribute Oxervate in Russia and Other CIS Countries

    Details:

    Dompé farmaceutici and FarmaMondo have inked Managed Access Program distribution agreement appointing the FarmaMondo as the exclusive partner to make Oxervate™ (Cenegermin) available for patients affected by Neurotrophic Keratitis in Russia and other CIS countries.


    Lead Product(s): Cenegermin

    Therapeutic Area: Ophthalmology Product Name: Oxervate

    Highest Development Status: ApprovedProduct Type: Large molecule

    Partner/Sponsor/Collaborator: Dompe Farmaceutici

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Agreement November 26, 2020

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-2024-05-06

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search